Cargando…
Combination versus single-agent as palliative chemotherapy for gastric cancer
BACKGROUND: Although combination chemotherapy (CC) is generally recommended in recurrent or primary metastatic gastric cancer (RPMGC), the results of randomized trials are conflicting. METHODS: A retrospective review was conducted on 687 RPMGC patients who received palliative chemotherapy. We compar...
Autores principales: | Choi, Jin-Hyuk, Choi, Yong Won, Kang, Seok Yun, Jeong, Geum Sook, Lee, Hyun Woo, Jeong, Seong Hyun, Park, Joon Seong, Ahn, Mi Sun, Sheen, Seung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052983/ https://www.ncbi.nlm.nih.gov/pubmed/32122320 http://dx.doi.org/10.1186/s12885-020-6666-1 |
Ejemplares similares
-
The role of surgical resection before palliative chemotherapy in advanced gastric cancer
por: Choi, Yong Won, et al.
Publicado: (2019) -
The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis
por: Choi, Yong Won, et al.
Publicado: (2018) -
Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
por: Kim, Tae-Hwan, et al.
Publicado: (2021) -
Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation
por: Choi, Yong Won, et al.
Publicado: (2015) -
The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study
por: Choi, Jin-Hyuk, et al.
Publicado: (2022)